Cancer gene therapy - JoVE Visualize

Showing results (961-970 of 2,903) with videos related to

Pageof 291

Sort By:

Cancer Gene Therapy|March 8, 2022

Silencing of RND3/RHOE inhibits the growth of human hepatocellular carcinoma and is associated with reversible senescenceSara Basbous, Lisa Paysan, Sandra Sena, et al.

Cancer Gene Therapy|March 4, 2000

Adenoviral transfer of xenogeneic MHC class I gene results in loss of tumorigenicity and inhibition of tumor growthI Campbell, T Moyana, S Carlsen, et al.

Cancer Gene Therapy|March 4, 2000

In vivo efficacy and toxicity of 5-fluorocytosine/cytosine deaminase gene therapy for malignant gliomas mediated by adenovirusT Ichikawa, T Tamiya, Y Adachi, et al.

Cancer Gene Therapy|March 4, 2000

Effectiveness of cancer vaccine therapy using cells transduced with the interleukin-12 gene combined with systemic interleukin-18 administrationI Hara, H Nagai, H Miyake, et al.

Cancer Gene Therapy|March 4, 2000

Attenuating the growth of tumors by intratumoral administration of DNA encoding Pseudomonas exotoxin via cationic liposomesN Yerushalmi, U Brinkmann, E Brinkmann, et al.

Cancer Gene Therapy|March 4, 2000

Purified herpes simplex thymidine kinase retroviral particles. II. Influence of clinical parameters and bystander killing mechanismsC A Kruse, C Lamb, S Hogan, et al.

Cancer Gene Therapy|March 4, 2000

Tetracycline-induced expression of an anti-c-Myb single-chain antibody and its inhibitory effect on proliferation of the human leukemia cell line K562K Kasono, Y Heike, J Xiang, et al.

Cancer Gene Therapy|July 27, 1999

The evaluation of adenoviral p53-mediated bystander effect in gene therapy of cancerN P Rizk, M Y Chang, C El Kouri, et al.

Cancer Gene Therapy|July 27, 1999

Phase I trial of interferon-gamma (IFN-gamma) retroviral vector administered intratumorally to patients with metastatic melanomaJ Nemunaitis, T Fong, J M Robbins, et al.

Cancer Gene Therapy|July 27, 1999

Human long-term culture initiating cells are sensitive to benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea and protected after mutant (G156A) methylguanine methyltransferase gene transferO N Koç, J S Reese, E M Szekely, et al.

Pageof 291

Showing results (961-970 of 2,903) with videos related to

Sort By:

Pageof 291

Cancer Gene Therapy|March 8, 2022

Silencing of RND3/RHOE inhibits the growth of human hepatocellular carcinoma and is associated with reversible senescenceSara Basbous, Lisa Paysan, Sandra Sena, et al.

Cancer Gene Therapy|March 4, 2000

Adenoviral transfer of xenogeneic MHC class I gene results in loss of tumorigenicity and inhibition of tumor growthI Campbell, T Moyana, S Carlsen, et al.

Cancer Gene Therapy|March 4, 2000

In vivo efficacy and toxicity of 5-fluorocytosine/cytosine deaminase gene therapy for malignant gliomas mediated by adenovirusT Ichikawa, T Tamiya, Y Adachi, et al.

Cancer Gene Therapy|March 4, 2000

Effectiveness of cancer vaccine therapy using cells transduced with the interleukin-12 gene combined with systemic interleukin-18 administrationI Hara, H Nagai, H Miyake, et al.

Cancer Gene Therapy|March 4, 2000

Attenuating the growth of tumors by intratumoral administration of DNA encoding Pseudomonas exotoxin via cationic liposomesN Yerushalmi, U Brinkmann, E Brinkmann, et al.

Cancer Gene Therapy|March 4, 2000

Purified herpes simplex thymidine kinase retroviral particles. II. Influence of clinical parameters and bystander killing mechanismsC A Kruse, C Lamb, S Hogan, et al.

Cancer Gene Therapy|March 4, 2000

Tetracycline-induced expression of an anti-c-Myb single-chain antibody and its inhibitory effect on proliferation of the human leukemia cell line K562K Kasono, Y Heike, J Xiang, et al.

Cancer Gene Therapy|July 27, 1999

The evaluation of adenoviral p53-mediated bystander effect in gene therapy of cancerN P Rizk, M Y Chang, C El Kouri, et al.

Cancer Gene Therapy|July 27, 1999

Phase I trial of interferon-gamma (IFN-gamma) retroviral vector administered intratumorally to patients with metastatic melanomaJ Nemunaitis, T Fong, J M Robbins, et al.

Cancer Gene Therapy|July 27, 1999

Human long-term culture initiating cells are sensitive to benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea and protected after mutant (G156A) methylguanine methyltransferase gene transferO N Koç, J S Reese, E M Szekely, et al.

Pageof 291